...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Accelerated approval

George, I agree on Pfizer. They are smart they got in on the inside for the cost of their drug but good to have them kicking the tires.

On financing, it strikes me as a signal that there remains enough private money interest so that going to the market may not be necessary (again).

Tic toc.

Toinv

Share
New Message
Please login to post a reply